Endpoint definition
↥Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
No definition available.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to
Abnormal findings in secretions and smears from cervix uteri vagina vulva
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 10542 | 10542 | - |
Unadjusted prevalence (%) | 4.05 | 7.17 | - |
Mean age at first event (years) | 41.29 | 41.29 | - |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.03 | 1.94 [1.40, 2.70] | 7.3e-5 | 216 |
15 years | 0.01 | 2.21 [1.61, 3.03] | 9.5e-7 | 171 |
5 years | 0.00 | 3.86 [2.75, 5.42] | 6.6e-15 | 62 |
1 year | 0.00 | 4.61 [2.54, 8.37] | 5.3e-7 | 13 |
Index endpoint: R18_ABNORMAL_FINDI_SECRE_SMEARS_CERVIX_UTERI_VAGINA_VULVA – Abnormal findings in secretions and smears from cervix uteri vagina vulva
GWS hits: 7
before Abnormal findings in secretions and smears from cervix uteri vagina vulva
after Abnormal findings in secretions and smears from cervix uteri vagina vulva
Loading survival analyses plot
Loading survival analyses table